THE PUPPETRY ARTS THEATRE, INC – Trademark Portfolio
Entity Type: 03
THE PUPPETRY ARTS THEATRE, INC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include TUFFY TIGER. The owner is based in Brooklyn, NY.
339 2nd St #1R
Brooklyn, NY 112152416
Showing of trademarks Trademarks
Trademark Classifications
THE PUPPETRY ARTS THEATRE, INC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does THE PUPPETRY ARTS THEATRE, INC have?
THE PUPPETRY ARTS THEATRE, INC has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 cancelled.
What trademark classes does THE PUPPETRY ARTS THEATRE, INC file in?
THE PUPPETRY ARTS THEATRE, INC files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 21 (Housewares). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are THE PUPPETRY ARTS THEATRE, INC's most well-known trademarks?
THE PUPPETRY ARTS THEATRE, INC's registered trademark portfolio includes well-known marks such as TUFFY TIGER. These are among 3 currently registered trademarks in the portfolio.
What is THE PUPPETRY ARTS THEATRE, INC's trademark registration success rate?
THE PUPPETRY ARTS THEATRE, INC has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.